83 FR 5109 - Meetings Announcement for the Physician-Focused Payment Model Technical Advisory Committee Required by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)
DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Register Volume 83, Issue 24 (February 5, 2018)
Federal Register Volume 83, Issue 24 (February 5, 2018)
| Page Range | 5109-5110 | |
| FR Document | 2018-02211 |
[Federal Register Volume 83, Number 24 (Monday, February 5, 2018)] [Notices] [Pages 5109-5110] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-02211] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Meetings Announcement for the Physician-Focused Payment Model Technical Advisory Committee Required by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) ACTION: Notice of public meetings. ----------------------------------------------------------------------- SUMMARY: This notice announces the 2018 meetings of the Physician- Focused Payment Model Technical Advisory Committee (hereafter referred to as ``the Committee'') which will be held in Washington, DC. This meeting will include voting and deliberations on proposals for physician-focused payment models (PFPMs) submitted by members of the public. All meetings are open to the public. DATES: The 2018 PTAC meetings will occur on the following dates:Monday-Tuesday, March 26-27, 2018, from 9:00 a.m. to 5:00 p.m. ET Thursday-Friday, June 14-15, 2018, from 9:00 a.m. to 5:00 p.m. ET Thursday-Friday, September 6-7, 2018, from 9:00 a.m. to 5:00 p.m. ET Monday-Tuesday, December 10-11, 2018, from 9:00 a.m. to 5:00 p.m. ET Please note that times are subject to change. If the times change, registrants will be notified directly via email. ADDRESSES: All PTAC meetings will be held in the Great Hall of the Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ann Page, Designated Federal Official, at the Office of Health Policy, Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services, 200 Independence Ave. SW, Washington, DC 20201, (202) 690-6870. SUPPLEMENTARY INFORMATION: I. Purpose. The Physician-Focused Payment Model Technical Advisory Committee (``the Committee'') is required by the Medicare Access and CHIP Reauthorization Act of 2015, 42 U.S.C. 1395ee. This Committee is also governed by provisions of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees. In accordance with its statutory mandate, the Committee is to review physician-focused payment model proposals and prepare recommendations regarding whether such models meet criteria that were established through rulemaking by the Secretary of Health and Human Services (the Secretary). The Committee is composed of 11 members appointed by the Comptroller General. II. Agenda. At each scheduled meeting, the Committee will hear presentations on PFPMs that are ready for Committee deliberation. The presentations will be followed by public comment and Committee deliberation. If the Committee completes deliberations, voting will occur on recommendations to the Secretary of Health and Human Services. There will be time allocated for public comment on agenda items. Documents will be posted on the Committee website and distributed on the Committee listserv prior to the public meeting. The agenda is subject to change. If the agenda does change, we will inform registrants and update the website. III. Meeting Attendance. These meetings are open to the public. The public may also attend via conference call or view the meeting via livestream at www.hhs.gov/live. The conference call dial-in information will be sent to registrants prior to the meeting. Meeting Registration: The public may attend the meetings in-person, participate by phone via audio teleconference, or view the meeting via livestream. Space is limited and registration is preferred in order to attend in-person or by phone. Registration may be completed online at www.regonline.com/PTACMeetingsRegistration. The following information is submitted when registering: Name: Company/organization name: Postal address: Email address: A confirmation email will be sent to registrants shortly after completing the registration process. IV. Special Accommodations. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact Angela Tejeda, no later than one week prior to the scheduled meeting. Please submit your requests by email to Angela.Tejeda@hhs.gov or by calling 202-401-8297. V. Copies of the PTAC Charter and Meeting Material. The Secretary's Charter for the Physician-Focused Payment Model Technical Advisory Committee is available on the ASPE website at https://aspe.hhs.gov/charter-physician-focused-payment-model-technical-advisory-committee. Additional material for this meeting can be found on the ASPE PTAC website. For updates and announcements, please use the link to subscribe to the ASPE PTAC email listserv. [[Page 5110]] Dated: January 31, 2018. John R. Graham, Acting Assistant Secretary for Planning and Evaluation. [FR Doc. 2018-02211 Filed 2-2-18; 8:45 am] BILLING CODE 4150-15-P
![Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices 5109
consolidation of the 0910–0012 DEPARTMENT OF HEALTH AND is composed of 11 members appointed
collection into this collection in 2004, HUMAN SERVICES by the Comptroller General.
we have included the estimated II. Agenda. At each scheduled
recordkeeping burden for medicated Meetings Announcement for the meeting, the Committee will hear
feed adverse event reports as part of our Physician-Focused Payment Model presentations on PFPMs that are ready
estimate of the recordkeeping burden of Technical Advisory Committee for Committee deliberation. The
all mandatory adverse event reports for Required by the Medicare Access and presentations will be followed by public
new animal drugs. To improve the CHIP Reauthorization Act of 2015 comment and Committee deliberation. If
clarity of our estimates we have added (MACRA) the Committee completes deliberations,
a row to table 2, on which we separately voting will occur on recommendations
ACTION: Notice of public meetings. to the Secretary of Health and Human
report our recordkeeping estimate for
SUMMARY: This notice announces the Services. There will be time allocated
medicated feed adverse event reports
2018 meetings of the Physician-Focused for public comment on agenda items.
(20 hours). Documents will be posted on the
Payment Model Technical Advisory
The burden of this collection has Committee website and distributed on
Committee (hereafter referred to as ‘‘the
changed. There was a slight increase in the Committee listserv prior to the
Committee’’) which will be held in
the estimated number of reports public meeting. The agenda is subject to
Washington, DC. This meeting will
submitted to FDA under total annual include voting and deliberations on change. If the agenda does change, we
responses (by 7.8 responses) and there proposals for physician-focused will inform registrants and update the
was a slight overall decrease in burden payment models (PFPMs) submitted by website.
hours (by 1.75 hours). This minor III. Meeting Attendance. These
members of the public. All meetings are
fluctuation in responses and hours is meetings are open to the public. The
open to the public.
due to the normal variation in the public may also attend via conference
DATES: The 2018 PTAC meetings will call or view the meeting via livestream
submission of reports to FDA, the occur on the following dates:
correction of mathematical errors, and a at www.hhs.gov/live. The conference
• Monday–Tuesday, March 26–27, call dial-in information will be sent to
change in reporting methodology 2018, from 9:00 a.m. to 5:00 p.m. ET
(addition of a new row to table 1 and registrants prior to the meeting.
• Thursday–Friday, June 14–15, 2018, Meeting Registration: The public may
table 2). from 9:00 a.m. to 5:00 p.m. ET attend the meetings in-person,
We continually strive to improve our • Thursday–Friday, September 6–7, participate by phone via audio
systems for collecting and analyzing 2018, from 9:00 a.m. to 5:00 p.m. ET teleconference, or view the meeting via
drug experience reports and adverse • Monday–Tuesday, December 10–11, livestream. Space is limited and
event reports. To that end, we have 2018, from 9:00 a.m. to 5:00 p.m. ET registration is preferred in order to
developed an electronic submission Please note that times are subject to attend in-person or by phone.
system by which Form FDA 2301 may change. If the times change, registrants Registration may be completed online at
be submitted to the Agency. For Form will be notified directly via email. www.regonline.com/PTACMeetings
FDA 1932a, we have a fillable electronic ADDRESSES: All PTAC meetings will be Registration.
form available online, which can be held in the Great Hall of the Hubert H. The following information is
submitted by email to FDA Center for Humphrey Building, 200 Independence submitted when registering:
Veterinary Medicine. We specifically Avenue SW, Washington, DC 20201. Name:
Company/organization name:
invite comment from respondents on FOR FURTHER INFORMATION CONTACT: Ann
Postal address:
the utility of these reporting forms. Page, Designated Federal Official, at the Email address:
Electronic adverse event reporting for Office of Health Policy, Assistant A confirmation email will be sent to
approved new animal drugs (including Secretary for Planning and Evaluation registrants shortly after completing the
mandatory reporting under § 514.80(b) (ASPE), U.S. Department of Health and registration process.
and voluntary reporting) has been Human Services, 200 Independence IV. Special Accommodations. If sign
approved under OMB control number Ave. SW, Washington, DC 20201, (202) language interpretation or other
0910–0645. Reporting and 690–6870. reasonable accommodation for a
recordkeeping associated with the index SUPPLEMENTARY INFORMATION: disability is needed, please contact
of legally marketed unapproved new I. Purpose. The Physician-Focused Angela Tejeda, no later than one week
animal drugs for minor species (21 CFR Payment Model Technical Advisory prior to the scheduled meeting. Please
part 516) is approved under OMB Committee (‘‘the Committee’’) is submit your requests by email to
control number 0910–0620. required by the Medicare Access and Angela.Tejeda@hhs.gov or by calling
CHIP Reauthorization Act of 2015, 42 202–401–8297.
Dated: January 30, 2018. U.S.C. 1395ee. This Committee is also V. Copies of the PTAC Charter and
Leslie Kux, governed by provisions of the Federal Meeting Material. The Secretary’s
Associate Commissioner for Policy. Advisory Committee Act, as amended (5 Charter for the Physician-Focused
[FR Doc. 2018–02234 Filed 2–2–18; 8:45 am] U.S.C. App.), which sets forth standards Payment Model Technical Advisory
BILLING CODE 4164–01–P
for the formation and use of federal Committee is available on the ASPE
advisory committees. In accordance website at https://aspe.hhs.gov/charter-
with its statutory mandate, the
sradovich on DSK3GMQ082PROD with NOTICES
physician-focused-payment-model-
Committee is to review physician- technical-advisory-committee.
focused payment model proposals and Additional material for this meeting
prepare recommendations regarding can be found on the ASPE PTAC
whether such models meet criteria that website. For updates and
were established through rulemaking by announcements, please use the link to
the Secretary of Health and Human subscribe to the ASPE PTAC email
Services (the Secretary). The Committee listserv.
VerDate Sep<11>2014 18:08 Feb 02, 2018 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\05FEN1.SGM 05FEN1](https://thefederalregister.org/doc/83_FR_5133/page/1.svg)
![5110 Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices
Dated: January 31, 2018. Endocrinology and Metabolic Diseases B Mental Health, NIH, Neuroscience Center,
John R. Graham, Subcommittee. 6001 Executive Blvd., Room 6151, MSC 9606,
Date: March 7–9, 2018. Bethesda, MD 20892–9606, 301–443–1606,
Acting Assistant Secretary for Planning and
Time: 8:00 p.m. to 3:00 p.m. charlesvi@mail.nih.gov.
Evaluation.
Agenda: To review and evaluate grant Name of Committee: National Institute of
[FR Doc. 2018–02211 Filed 2–2–18; 8:45 am] applications. Mental Health Special Emphasis Panel;
BILLING CODE 4150–15–P Place: Doubletree Hotel Bethesda Clinical Trial and K Awards Review Meeting.
(Formerly Holiday Inn Select), 8120 Date: February 27, 2018.
Wisconsin Avenue, Bethesda, MD 20814. Time: 9:00 a.m. to 5:00 p.m.
DEPARTMENT OF HEALTH AND Contact Person: John F. Connaughton, Agenda: To review and evaluate grant
HUMAN SERVICES Ph.D., Chief, Scientific Review Branch, applications.
Review Branch, DEA, NIDDK, National Place: Hyatt Regency Bethesda, One
National Institutes of Health Institutes of Health, Room 7007, 6707 Bethesda Metro Center, 7400 Wisconsin
Democracy Boulevard, Bethesda, MD 20892– Avenue, Bethesda, MD 20814.
National Institute of Diabetes and 5452, (301) 594–7797, connaughtonj@ Contact Person: David I. Sommers, Ph.D.,
Digestive and Kidney Diseases; Notice extra.niddk.nih.gov. Scientific Review Officer, Division of
of Closed Meetings (Catalogue of Federal Domestic Assistance Extramural Activities, National Institute of
Program Nos. 93.847, Diabetes, Mental Health, National Institutes of Health,
Pursuant to section 10(d) of the Endocrinology and Metabolic Research; 6001 Executive Blvd., Room 6154, MSC 9606,
Federal Advisory Committee Act, as 93.848, Digestive Diseases and Nutrition Bethesda, MD 20892, 301–443–7861,
amended, notice is hereby given of the Research; 93.849, Kidney Diseases, Urology dsommers@mail.nih.gov.
following meetings. and Hematology Research, National Institutes Name of Committee: National Institute of
of Health, HHS) Mental Health Special Emphasis Panel;
The meetings will be closed to the
Integration and Analysis of BRAIN Initiative
public in accordance with the Dated: January 31, 2018. Data (R24).
provisions set forth in sections David Clary, Date: February 28, 2018
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Program Analyst, Office of Federal Advisory Time: 12:00 p.m. to 5:00 p.m.
as amended. The grant applications and Committee Policy. Agenda: To review and evaluate grant
the discussions could disclose [FR Doc. 2018–02253 Filed 2–2–18; 8:45 am] applications.
confidential trade secrets or commercial Place: National Institutes of Health,
BILLING CODE 4140–01–P
property such as patentable material, Neuroscience Center, 6001 Executive
and personal information concerning Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
individuals associated with the grant DEPARTMENT OF HEALTH AND Contact Person: Vinod Charles, Ph.D.,
applications, the disclosure of which HUMAN SERVICES Scientific Review Officer, Division of
would constitute a clearly unwarranted Extramural Activities, National Institute of
invasion of personal privacy. National Institutes of Health Mental Health, NIH, Neuroscience Center,
Name of Committee: National Institute of 6001 Executive Blvd., Room 6151, MSC 9606,
National Institute of Mental Health; Bethesda, MD 20892–9606, 301–443–1606,
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Kidney, Urologic and Notice of Closed Meetings charlesvi@mail.nih.gov.
Hematologic Diseases D Subcommittee. (Catalogue of Federal Domestic Assistance
Pursuant to section 10(d) of the Program No. 93.242, Mental Health Research
Date: February 21–22, 2018. Federal Advisory Committee Act, as
Time: 8:00 a.m. to 3:00 p.m. Grants, National Institutes of Health, HHS)
Agenda: To review and evaluate grant
amended, notice is hereby given of the
following meetings. Dated: January 31, 2018.
applications. Melanie J. Pantoja,
Place: Hyatt Regency Bethesda, One The meetings will be closed to the
Bethesda Metro Center, 7400 Wisconsin public in accordance with the Program Analyst, Office of Federal Advisory
Avenue, Bethesda, MD 20814. provisions set forth in sections Committee Policy.
Contact Person: Barbara A. Woynarowska, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., [FR Doc. 2018–02251 Filed 2–2–18; 8:45 am]
Ph.D., Scientific Review Administrator, as amended. The grant applications and BILLING CODE 4140–01–P
Review Branch, DEA, NIDDK, National the discussions could disclose
Institutes of Health, Room 7007, 6707 confidential trade secrets or commercial
Democracy Boulevard, Bethesda, MD 20892– property such as patentable material, DEPARTMENT OF HEALTH AND
5452, (301) 402–7172, woynarowskab@ HUMAN SERVICES
niddk.nih.gov.
and personal information concerning
individuals associated with the grant
Name of Committee: National Institute of National Institutes of Health
Diabetes and Digestive and Kidney Diseases
applications, the disclosure of which
Initial Review Group; Digestive Diseases and would constitute a clearly unwarranted National Cancer Institute; Amended
Nutrition C Subcommittee. invasion of personal privacy. Notice of Meeting
Date: March 7–9, 2018. Name of Committee: National Institute of
Time: 6:00 p.m. to 10:30 a.m. Mental Health Special Emphasis Panel; Data Notice is hereby given of a change in
Agenda: To review and evaluate grant Archives for the BRAIN Initiative (R24) and the meeting of the National Cancer
applications. Standards To Define Experiments Related to Institute Special Emphasis Panel, March
Place: Residence Inn Bethesda, 7335 the BRAIN Initiative (R24). 13, 2018, 4:00 p.m. to March 14, 2018,
Wisconsin Avenue, Bethesda, MD 20814. Date: February 26, 2018. 5:00 p.m., Bethesda North Marriott
Contact Person: Maria E. Davila-Bloom, Time: 12:30 p.m. to 4:30 p.m. Hotel & Conference Center, 5701
Ph.D., Scientific Review Officer, Review Agenda: To review and evaluate grant
sradovich on DSK3GMQ082PROD with NOTICES
Branch, DEA, NIDDK, National Institutes of
Marinelli Road, North Bethesda, MD
applications. 20852 which was published in the
Health, Room 7017, 6707 Democracy Place: National Institutes of Health,
Boulevard, Bethesda, MD 20892–5452, (301) Neuroscience Center, 6001 Executive
Federal Register on January 11, 2018, 83
594–7637, davila-bloomm@ Boulevard, Rockville, MD 20852 (Telephone FR 1378.
extra.niddk.nih.gov. Conference Call). This meeting notice is amended to
Name of Committee: National Institute of Contact Person: Vinod Charles, Ph.D., change the meeting name from ‘‘TEP–1:
Diabetes and Digestive and Kidney Diseases Scientific Review Officer, Division of Development of Software Tools for Post
Initial Review Group; Diabetes, Extramural Activities, National Institute of Radiation Therapy Surveillance’’ to
VerDate Sep<11>2014 18:08 Feb 02, 2018 Jkt 244001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\05FEN1.SGM 05FEN1](https://thefederalregister.org/doc/83_FR_5133/page/2.svg)
Document Created: 2018-02-03 01:24:57
Document Modified: 2018-02-03 01:24:57
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of public meetings. | |
| Dates | The 2018 PTAC meetings will occur on the following dates: | |
| Contact | Ann Page, Designated Federal Official, at the Office of Health Policy, Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services, 200 Independence Ave. SW, Washington, DC 20201, (202) 690-6870. | |
| FR Citation | 83 FR 5109 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR